The Federal Trade Commission said pharmacy benefit managers created a "perverse drug rebate system" that artificially ...

The FTC suit targets the three biggest so-called pharmacy benefit managers, UnitedHealth Group's Optum Rx, CVS Health's ...

FTC Sues Prescription Drug Middlemen for Artificially Inflating Insulin Drug Prices – Includes Caremark, Express Scripts, ...

The Federal Trade Commission Friday announced it was suing the country's three biggest pharmacy benefit managers, claiming ...

The U.S. Federal Trade Commission sued the country's three largest pharmacy benefit managers on Friday, accusing them of ...

Humira dropped from last of the big drug middlemen's preferred lists As obesity drugs reshape the pharma world, Eli Lilly eyes AbbVie's wheelhouse One of AbbVie's rivals in the schizophrenia ...

Aug 27 (Reuters) - Eli Lilly (LLY.N), opens new tab said on Tuesday ... Seigerman said that would allow the company to more easily sue those selling compounded versions of Zepbound.

(Reuters) - Eli Lilly said on Tuesday it has begun selling ... Seigerman said that would allow the company to more easily sue those selling compounded versions of Zepbound. Shares of Hims and ...

Lilly Launches Vials of Weight-Loss Drug Zepbound for as Low as $399 a Month By Patrick Wingrove (Reuters) - Eli Lilly said on ... the company to more easily sue those selling compounded versions ...

Eli Lilly & Co. is seeking to block the FDA’s decision to designate its obesity medicine, retatrutide, as a drug instead of a biological product. The Food and Drug Administration’s determination that ...

Eli Lilly said today it has begun selling vials ... Seigerman said that would allow the company to more easily sue those selling compounded versions of Zepbound. Shares of Hims and Hers Health ...

Eli Lilly, Novo Nordisk and Sanofi control 99% of the insulin market. An Eli Lilly spokesperson says the lawsuit's allegations are "baseless." The school district is self-insured, meaning it foots the ...